Eton Pharmaceuticals, Inc. Earnings Per Share (Basic)
Eton Pharmaceuticals, Inc. (ETON) reported Earnings Per Share (Basic) of $0.42 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Eton Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.42.
- Eton Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.06.
- Eton Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.07, a 450.00% decline year-over-year.
- Eton Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.10.
- Eton Pharmaceuticals, Inc. earnings per share, basic for fiscal 2025 was -$0.17.
- Eton Pharmaceuticals, Inc. earnings per share, basic for fiscal 2024 was -$0.15.
- Eton Pharmaceuticals, Inc. earnings per share, basic for fiscal 2023 was -$0.04.
- Eton Pharmaceuticals, Inc. earnings per share, basic for fiscal 2022 was -$0.36.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.42 10-Q · filed 2026-08-13 | $0.48 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $0.06 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | -$0.17 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | -$0.07 10-Q · filed 2025-11-06 | -$0.23 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$0.10 10-Q · filed 2026-08-13 | -$0.15 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | -$0.06 10-Q · filed 2026-05-14 | ||||
| 2024-12-31 | -$0.15 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | $0.02 10-Q · filed 2025-11-06 | -$0.12 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$0.12 10-Q · filed 2025-08-07 | -$0.15 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | -$0.03 10-Q · filed 2025-05-13 | ||||
| 2023-12-31 | -$0.04 10-K · filed 2026-03-19 | ||||
| 2023-09-30 | -$0.02 10-Q · filed 2024-11-12 | $0.05 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $0.18 10-Q · filed 2024-08-08 | $0.07 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$0.10 10-Q · filed 2024-05-09 | -$100.00 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | -$0.36 10-K · filed 2025-03-18 | ||||
| 2022-09-30 | -$0.12 10-Q · filed 2023-11-09 | -$0.40 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$0.06 10-Q · filed 2023-08-10 | -$0.28 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | -$210.00 10-Q · filed 2023-05-11 | -$0.21 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | -$0.08 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | -$0.24 10-Q · filed 2022-11-10 | -$0.12 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | -$0.08 10-Q · filed 2022-08-11 | $0.12 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $0.21 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | -$1.33 10-K · filed 2023-03-16 | ||||
| 2020-06-30 | -$0.23 10-Q · filed 2021-08-16 | -$0.70 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | -$0.50 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |